T

Twist Bioscience Corp
D

TWST

42.230
USD
0.58
(1.39%)
Market Closed
Volume
64,539
EPS
0
Div Yield
-
P/E
-12
Market Cap
2,506,622,461
Related Instruments
    C
    CDNA
    -0.400
    (-1.86%)
    21.160 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    F
    FATE
    -0.04500
    (-2.17%)
    2.02500 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    N
    NTRA
    -5.120
    (-3.39%)
    146.040 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    R
    RPTX
    -0.14000
    (-4.31%)
    3.11000 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    T
    TCON
    0.00000
    (0.00%)
    1.45000 USD
    More
News

Title: Twist Bioscience Corp

Sector: Healthcare
Industry: Diagnostics & Research
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.